基因组
计算生物学
风险分析(工程)
数据科学
计算机科学
生物
业务
基因
遗传学
作者
Charles Y. Chiu,F. Xavier López‐Labrador,Michael R. Wilson,Jutte J.C. de Vries
标识
DOI:10.1001/jamaneurol.2025.0461
摘要
This Viewpoint discusses regulatory shifts and their effects on access to innovative diagnostic tests and provides ways to address regulatory barriers for clinical metagenomic testing.
科研通智能强力驱动
Strongly Powered by AbleSci AI